Quality control of actinium-225 and 225Ac-radiopharmaceuticals: Francium-221 to be or not to be?
Abstract Background Actinium-225 radiopharmaceuticals have drawn great interest in cancer therapy due to their tumor-specific delivery of cytotoxic alpha-particles. Quality control (QC) is critical for these potent agents and there is currently no consensus for best practice of actinium-225 QC. Dete...
Guardat en:
| Autors principals: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SpringerOpen
2026-01-01
|
| Col·lecció: | EJNMMI Radiopharmacy and Chemistry |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s41181-025-00419-7 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
